
(1) | Adjusted net income per diluted share is a non-GAAP financial measure which is calculated as: “Adjusted net income attributable to company” divided by “Diluted weighted average common shares outstanding.” Management believes adjusted net income per diluted share is useful to investors to assess and understand operating performance. See Reconciliation of Net Income Attributable to Company to Adjusted Net Income Attributable to Company in Footnote Table 2. | |
(2) | Adjusted operating margin is a non-GAAP financial measure which is calculated by dividing “Adjusted operating income” by “Total revenue.” Management believes adjusted operating margin is useful to investors to assess and understand operating performance. See Reconciliation of Operating Income to Adjusted Operating Income in Footnote Table 1. | |
(3) | Free cash flow is a non-GAAP financial measure which is calculated as “Total cash flows provided by operating activities” less “Capital expenditures” plus “Proceeds from sales of property, plant, and equipment.” Management believes that free cash flow is a key measure to assess liquidity of the business and is consistent with the disclosures of Halliburton's direct, large- cap competitors. See Reconciliation of Cash Flows from Operating Activities to Free Cash Flow in Footnote Table 3. | |
(4) | Adjusted net income attributable to company is a non-GAAP financial measure which is calculated as: “Net income attributable to company” plus “Total adjustments, net of taxes” for the respective periods. Management believes adjusted net income is useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods or forecasting performance for future periods, primarily because management views the excluded items to be outside of the company's normal operating results. Management analyzes net income without the impact of these items as an indicator of performance to identify underlying trends in the business and to establish operational goals. Total adjustments remove the effect of these items. See Reconciliation of Net Income Attributable to Company to Adjusted Net Income Attributable to Company in Footnote Table 2. | |
(5) | Adjusted EBITDA is a non-GAAP financial measure which is calculated as: “Net income,” before “Interest expense, net,” “Income tax provision,” “Depreciation, depletion, and amortization,” and excludes “Impairments and other charges (credits).” Management believes Adjusted EBITDA is a key measure to assess and understand operating performance and is consistent with the disclosures of Halliburton’s direct, large-cap competitors. See EBITDA, Adjusted EBITDA, Related Margins, and Reconciliations schedule. | |
(6) | Adjusted operating income is a non-GAAP financial measure which is calculated as: “Operating income” plus “Total impairments and other charges (credits)” for the respective periods. Management believes that operating income adjusted for impairments and other charges (credits) is useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods or forecasting performance for future periods, primarily because management views the excluded items to be outside of the company's normal operating results. Management analyzes operating income without the impact of these items as an indicator of performance, to identify underlying trends in the business, and to establish operational goals. The adjustments remove the effect of these items. See Reconciliation of Operating Income to Adjusted Operating Income in Footnote Table 1. | |
Three Months Ended | Nine Months Ended | |||||
September 30, | June 30, | September 30, | ||||
2026 | 2025 | 2026 | 2026 | 2025 | ||
Revenue: | ||||||
Completion and Production | $3,089 | $3,223 | $3,202 | $9,307 | $9,514 | |
Drilling and Evaluation | 2,614 | 2,377 | 2,512 | 7,512 | 7,013 | |
Total revenue | $5,703 | $5,600 | $5,714 | $16,819 | $16,527 | |
Operating income: | ||||||
Completion and Production | $457 | $514 | $474 | $1,370 | $1,558 | |
Drilling and Evaluation | 391 | 348 | 338 | 1,080 | 1,012 | |
Corporate and other | (75) | (64) | (83) | (227) | (196) | |
SAP S4 upgrade expense | (42) | (50) | (46) | (130) | (112) | |
Impairments and other (charges) credits (a) | (107) | (392) | 95 | (12) | (748) | |
Total operating income | 624 | 356 | 778 | 2,081 | 1,514 | |
Interest expense, net | (84) | (88) | (83) | (249) | (266) | |
Other, net (b) | (27) | (49) | (31) | (86) | (112) | |
Income before income taxes | 513 | 219 | 664 | 1,746 | 1,136 | |
Income tax provision (c) | (94) | (199) | (126) | (325) | (433) | |
Net income | $419 | $20 | $538 | $1,421 | $703 | |
Net income attributable to noncontrolling interest | (2) | (2) | (4) | (9) | (9) | |
Net income attributable to company | $417 | $18 | $534 | $1,412 | $694 | |
Basic and diluted net income per share | $0.50 | $0.02 | $0.64 | $1.69 | $0.81 | |
Basic weighted average common shares outstanding | 831 | 849 | 836 | 835 | 857 | |
Diluted weighted average common shares outstanding | 832 | 850 | 838 | 836 | 858 | |
(a) | See Footnote Table 1 for details of the impairments and other (charges) credits recorded during the three and nine months ended September 30, 2026 and 2025, and the three months ended June 30, 2026. | |||||
(b) | During the three and nine months ended September 30, 2025, Halliburton incurred a charge of $23 million due to the impairment of an investment in Argentina. | |||||
(c) | During the three and nine months ended September 30, 2026 and the three months ended June 30, 2026, the income tax provision includes the tax effect on impairments and other (charges) credits. The income tax provision during the three and nine months ended September 30, 2025 includes a $125 million tax expense associated with a valuation allowance recorded against our United States foreign tax credits, as well as the tax effect on impairments and other charges and the impairment of an investment in Argentina. | |||||
See Footnote Table 1 for Reconciliation of Operating Income to Adjusted Operating Income. | ||||||
See Footnote Table 2 for Reconciliation of Net Income Attributable to Company to Adjusted Net Income Attributable to Company. | ||||||
September 30, | December 31, | |||
2026 | 2025 | |||
Assets | ||||
Current assets: | ||||
Cash and equivalents | $1,843 | $2,206 | ||
Receivables, net | 5,515 | 4,942 | ||
Inventories | 3,265 | 2,976 | ||
Other current assets | 1,517 | 1,274 | ||
Total current assets | 12,140 | 11,398 | ||
Property, plant, and equipment, net | 5,152 | 5,261 | ||
Goodwill | 3,021 | 2,938 | ||
Deferred income taxes | 2,377 | 2,298 | ||
Operating lease right-of-use assets | 1,018 | 938 | ||
Other assets | 2,365 | 2,177 | ||
Total assets | $26,073 | $25,010 | ||
Liabilities and Shareholders' Equity | ||||
Current liabilities: | ||||
Accounts payable | $3,535 | $3,133 | ||
Accrued employee compensation and benefits | 788 | 767 | ||
Current portion of operating lease liabilities | 276 | 263 | ||
Current maturities of long-term debt | 90 | — | ||
Other current liabilities | 1,323 | 1,425 | ||
Total current liabilities | 6,012 | 5,588 | ||
Long-term debt | 7,072 | 7,158 | ||
Operating lease liabilities | 760 | 712 | ||
Employee compensation and benefits | 431 | 428 | ||
Other liabilities | 637 | 619 | ||
Total liabilities | 14,912 | 14,505 | ||
Company shareholders’ equity | 11,118 | 10,461 | ||
Noncontrolling interest in consolidated subsidiaries | 43 | 44 | ||
Total shareholders’ equity | 11,161 | 10,505 | ||
Total liabilities and shareholders’ equity | $26,073 | $25,010 | ||
Nine Months Ended | Three Months Ended | ||
September 30, | September 30, | ||
2026 | 2025 | 2026 | |
Cash flows from operating activities: | |||
Net income | $1,421 | $703 | $419 |
Adjustments to reconcile net income to cash flows from operating activities: | |||
Depreciation, depletion, and amortization | 887 | 846 | 296 |
Impairments and other charges | 12 | 748 | 107 |
Working capital (a) | (517) | (111) | (330) |
Other operating activities | (338) | (425) | (124) |
Total cash flows provided by operating activities | 1,465 | 1,761 | 368 |
Cash flows from investing activities: | |||
Capital expenditures | (693) | (917) | (266) |
Purchases of investment securities | (111) | (128) | (18) |
Payments to acquire businesses | (107) | (175) | — |
Purchases of equity investments | (101) | (343) | — |
Proceeds from sales of property, plant, and equipment | 175 | 138 | 54 |
Sales of investment securities | 65 | 228 | 16 |
Sale of an equity investment | 50 | 120 | 50 |
Other investing activities | (48) | (49) | 20 |
Total cash flows used in investing activities | (770) | (1,126) | (144) |
Cash flows from financing activities: | |||
Stock repurchase program | (558) | (757) | (250) |
Dividends to shareholders | (426) | (436) | (141) |
Other financing activities | (52) | (23) | (26) |
Total cash flows used in financing activities | (1,036) | (1,216) | (417) |
Effect of exchange rate changes on cash | (22) | (11) | (12) |
Decrease in cash and equivalents | (363) | (592) | (205) |
Cash and equivalents at beginning of period | 2,206 | 2,618 | 2,048 |
Cash and equivalents at end of period | $1,843 | $2,026 | $1,843 |
(a) | Working capital includes receivables, inventories, and accounts payable. | ||||||||
See Footnote Table 3 for Reconciliation of Cash Flows from Operating Activities to Free Cash Flow. | |||||||||
Three Months Ended | Nine Months Ended | |||||
September 30, | June 30, | September 30, | ||||
2026 | 2025 | 2026 | 2026 | 2025 | ||
Net income attributable to company | $417 | $18 | $534 | $1,412 | $694 | |
Net income attributable to noncontrolling interest | 2 | 2 | 4 | 9 | 9 | |
Net Income | $419 | $20 | $538 | $1,421 | $703 | |
Interest expense, net | 84 | 88 | 83 | 249 | 266 | |
Income tax provision | 94 | 199 | 126 | 325 | 433 | |
Depreciation, depletion, and amortization | 296 | 285 | 296 | 887 | 846 | |
EBITDA (a) | $893 | $592 | $1,043 | $2,882 | $2,248 | |
Other, net (b) | — | 23 | — | — | 23 | |
Impairments and other charges (credits) (c) | 107 | 392 | (95) | 12 | 748 | |
Adjusted EBITDA | $1,000 | $1,007 | $948 | $2,894 | $3,019 | |
Total revenue | $5,703 | $5,600 | $5,714 | $16,819 | $16,527 | |
Net income attributable to company margin | 7.3% | 0.3% | 9.3% | 8.4% | 4.2% | |
Net income margin | 7.3% | 0.4% | 9.4% | 8.4% | 4.3% | |
EBITDA margin (a) | 15.7% | 10.6% | 18.3% | 17.1% | 13.6% | |
Adjusted EBITDA margin (d) | 17.5% | 18.0% | 16.6% | 17.2% | 18.3% | |
(a) | EBITDA and EBITDA margin are non-GAAP financial measures. EBITDA is calculated as “Net income” before “Interest expense, net,” “Income tax provision” and “Depreciation, depletion, and amortization” for the respective periods. EBITDA margin is calculated as “EBITDA” divided by “Total revenue.” Management believes EBITDA and EBITDA margin are key measures to assess and understand operating performance and are consistent with the disclosures of Halliburton’s direct, large-cap competitors. | |||||
(b) | For the three and nine months ended September 30, 2025, adjusted EBITDA excludes a $23 million impairment on an investment in Argentina. | |||||
(c) | See Footnote Table 1 for details of the impairments and other charges (credits) recorded during the three and nine months ended September 30, 2026 and 2025, and the three months ended June 30, 2026. | |||||
(d) | Adjusted EBITDA margin is a non-GAAP financial measure which is calculated as: “Adjusted EBITDA” divided by “Total revenue.” Management believes Adjusted EBITDA margin is a key measure to assess and understand operating performance and is consistent with disclosures of Halliburton's direct, large-cap competitors. | |||||
Three Months Ended | ||||||||
September 30, | September 30, | June 30, | ||||||
2026 | 2025 | 2026 | ||||||
Completion and Production | Drilling and Evaluation | Completion and Production | Drilling and Evaluation | Completion and Production | Drilling and Evaluation | |||
Revenue | $3,089 | $2,614 | $3,223 | $2,377 | $3,202 | $2,512 | ||
Operating income | $457 | $391 | $514 | $348 | $474 | $338 | ||
Depreciation, depletion, and amortization | 161 | 126 | 156 | 123 | 162 | 126 | ||
Segment EBITDA (a) | $618 | $517 | $670 | $471 | $636 | $464 | ||
Operating margin | 14.8% | 15.0% | 15.9% | 14.6% | 14.8% | 13.5% | ||
Segment EBITDA margin (a) | 20.0% | 19.8% | 20.8% | 19.8% | 19.9% | 18.5% | ||
Nine Months Ended | |||||
September 30, | September 30, | ||||
2026 | 2025 | ||||
Completion and Production | Drilling and Evaluation | Completion and Production | Drilling and Evaluation | ||
Revenue | $9,307 | $7,512 | $9,514 | $7,013 | |
Operating income | $1,370 | $1,080 | $1,558 | $1,012 | |
Depreciation, depletion, and amortization | 486 | 378 | 462 | 368 | |
Segment EBITDA (a) | $1,856 | $1,458 | $2,020 | $1,380 | |
Operating margin | 14.7% | 14.4% | 16.4% | 14.4% | |
Segment EBITDA margin (a) | 19.9% | 19.4% | 21.2% | 19.7% | |
(a) | Segment EBITDA and Segment EBITDA margin are non-GAAP financial measures. Segment EBITDA is calculated as segment “Operating income” plus “Depreciation, depletion, and amortization” for the respective periods. Segment EBITDA margin is calculated as “Segment EBITDA” divided by segment “Revenue”. Management believes Segment EBITDA and Segment EBITDA margin are key measures to assess and understand segment operating performance and are consistent with the disclosures of Halliburton’s direct, large-cap competitors. | |
Three Months Ended | Nine Months Ended | |||||
September 30, | June 30, | September 30, | ||||
Revenue | 2026 | 2025 | 2026 | 2026 | 2025 | |
North America | $2,160 | $2,364 | $2,276 | $6,572 | $6,859 | |
Latin America | 1,122 | 996 | 1,123 | 3,335 | 2,869 | |
Europe/Africa/CIS | 1,016 | 828 | 1,017 | 2,891 | 2,423 | |
Middle East/Asia | 1,405 | 1,412 | 1,298 | 4,021 | 4,376 | |
Total revenue | $5,703 | $5,600 | $5,714 | $16,819 | $16,527 | |
Three Months Ended | Nine Months Ended | ||||||
September 30, | June 30, | September 30, | |||||
2026 | 2025 | 2026 | 2026 | 2025 | |||
Operating income | $624 | $356 | $778 | $2,081 | $1,514 | ||
Impairments and other charges (credits): | |||||||
Severance costs | 107 | 169 | — | 107 | 276 | ||
Inventory costs and write-downs | 25 | — | — | 25 | — | ||
Fixed and other assets write-offs | 14 | 115 | — | 14 | 115 | ||
Impairment of assets held for sale | — | 96 | — | — | 200 | ||
Loss on sale of a business | — | — | 17 | 17 | — | ||
Impairment of real estate facilities | — | — | — | — | 53 | ||
Cybersecurity incident | — | (10) | — | — | (10) | ||
Gain on investments | (36) | (6) | (64) | (100) | (6) | ||
Other | (3) | 28 | (48) | (51) | 120 | ||
Total impairments and other charges (credits) (a) (b) | 107 | 392 | (95) | 12 | 748 | ||
Adjusted operating income | $731 | $748 | $683 | $2,093 | $2,262 | ||
Total revenue | $5,703 | $5,600 | $5,714 | $16,819 | $16,527 | ||
Operating income margin | 10.9% | 6.4% | 13.6% | 12.4% | 9.2% | ||
Adjusted operating income margin | 12.8% | 13.4% | 12.0% | 12.4% | 13.7% | ||
(a) | During the three months ended September 30, 2026, Halliburton recognized a pre-tax charge of $107 million primarily related to $107 million of severance costs associated with the rationalization of our global headcount, and $25 million of inventory costs and write-downs, partially offset by a $36 million gain resulting from the sale of a portion of our shares in an equity investment. During the three months ended June 30, 2026, Halliburton recognized a pre-tax credit of $95 million primarily due to a $54 million gain resulting from changes in our ownership interest in an equity investment, and a $10 million gain from remeasuring an equity investment to fair value. Other credits of $48 million were primarily due to a government refund recovery. These gains were partially offset by a $17 million loss on the sale of a portion of our chemical business, which closed in April 2026. During the three months ended September 30, 2025, Halliburton recognized a pre-tax charge of $392 million as a result of severance costs, fixed and other assets write-offs, an impairment of assets held for sale, and other items. | |||||
(b) | During the nine months ended September 30, 2026, Halliburton recognized a pre-tax charge of $12 million primarily related to $107 million of severance costs associated with the rationalization of our global headcount, partially offset by a $102 million gain primarily related to a $54 million gain resulting from changes in our ownership interest in an equity investment and a $36 million gain resulting from the sale of a portion of our shares in an equity investment. During the nine months ended September 30, 2025, Halliburton recognized a pre-tax charge of $748 million as a result of severance costs, an impairment of assets held for sale, an impairment on real estate facilities, and other items, primarily related to legacy environmental remediation cost estimate increases. | |||||
Three Months Ended | Nine Months Ended | ||||||
September 30, | June 30, | September 30, | |||||
2026 | 2025 | 2026 | 2026 | 2025 | |||
Net income attributable to company | $417 | $18 | $534 | $1,412 | $694 | ||
Adjustments: | |||||||
Impairments and other charges (credits) (a) | 107 | 392 | (95) | 12 | 748 | ||
Other, net (b) | — | 23 | — | — | 23 | ||
Total adjustments, before taxes | 107 | 415 | (95) | 12 | 771 | ||
Tax valuation allowance (c) | — | 125 | — | — | 125 | ||
Tax adjustment (c) | (23) | (62) | 22 | (1) | (105) | ||
Total adjustments, net of taxes | 84 | 478 | (73) | 11 | 791 | ||
Adjusted net income attributable to company | $501 | $496 | $461 | $1,423 | $1,485 | ||
Diluted weighted average common shares outstanding | 832 | 850 | 838 | 836 | 858 | ||
Net income per diluted share | $0.50 | $0.02 | $0.64 | $1.69 | $0.81 | ||
Adjusted net income per diluted share | $0.60 | $0.58 | $0.55 | $1.70 | $1.73 | ||
(a) | See Footnote Table 1 for details of the impairments and other charges (credits) recorded during the three and nine months ended September 30, 2026 and 2025, and the three months ended June 30, 2026. | |||||
(b) | During the three and nine months ended September 30, 2025, Halliburton incurred a charge of $23 million due to the impairment of an investment in Argentina. | |||||
(c) | During the three and nine months ended September 30, 2026 and the three months ended June 30, 2026, the adjustment includes the tax effect on impairments and other charges (credits). During the three and nine months ended September 30, 2025, the adjustments in the table above include a $125 million tax expense associated with a valuation allowance recorded against our deferred tax assets, which resulted from the impact on the realizability of our United States foreign tax credits due to the “One Big Beautiful Bill Act” (OBBBA), as well as the tax effect on impairments and other charges and the impairment of an investment in Argentina. | |||||
Nine Months Ended | Three Months Ended | ||
September 30, | September 30, | ||
2026 | 2025 | 2026 | |
Total cash flows provided by operating activities | $1,465 | $1,761 | $368 |
Capital expenditures | (693) | (917) | (266) |
Proceeds from sales of property, plant, and equipment | 175 | 138 | 54 |
Free cash flow | $947 | $982 | $156 |